Streetwise Reports' Article Archives — November 2017 back to current month (16)

Potential Alzheimer's Therapies Focus on Early Intervention (11/30/2017)

After attending a conference on the latest in development of Alzheimer's disease treatments, Andrew Fein, an analyst with H.C. Wainwright & Co., provided an industry update.


Analysts Say Medical Device Firm Sees Record Quarterly Revenue Growth, 120% YOY (11/29/2017)

Following the company's release of its latest financial report, three analysts weighed in on the results.


Analyst's 'Top Pick' Advances Vaccine Candidates (11/21/2017)

Douglas Loe, an analyst with Echelon Wealth Partners, provided an update on this biotech's platform pipeline targeting ovarian and blood cancers, as well as respiratory syncytial virus.


Stock Price Jump Reflects Biotech's Active October (11/20/2017)

This immunotherapy firm's stock recently doubled its Nov. 7 price following lots of news, including a clinical data release, a trial launch and an executive appointment.


Maxim's Target Price on Biotech Makes It More Than a Tenbagger (11/20/2017)

Jason Kolbert, an analyst with Maxim Group, provided an update on this biopharmaceutical firm's two recently acquired oncology assets.


'Hot' Alzheimer's Market is Promising for Biotech with 'Novel' Drug Candidate (11/20/2017)

André Uddin, an analyst with Mackie Research Capital Corp., summarized the quarterly financial results and anticipated catalysts for this Alzheimer's drug developer.


Biotech's Target Price Increased as Shares 'Deeply Undervalued' (11/15/2017)

Wedbush analyst Robert Driscoll provided an update on the lead asset of this drug developer targeting cancer.


Biotech Targets 'Blockbuster' Markets; Less-Addictive Opioid Painkiller Set for FDA Filing (11/15/2017)

Medical Technology Stock Letter editor John McCamant outlines the reasons behind the buy rating and target price increases for a company that, in addition to developing an alternative to addictive opioids for pain relief, has candidates targeting multiple immune disorders and cancer.


The Lowdown on Getting High in Canada (11/14/2017)

Some 600 tonnes of marijuana a year are up for grabs as Canada moves to legalize weed, says Rick Mills, founder of Ahead of the Herd, who puts forth his case on why cannabis stocks should be in every investor's portfolio.


Analyst Says Biotech Share Price Could Potentially 'Double' (11/13/2017)

Analyst Grant Zeng of Zacks Small Cap Research examines what transpired with this biopharmaceutical company during Q3/17.


Biotech with Solid Pipeline and 'Solid Partnership Outlook' (11/13/2017)

Analyst Kevin DeGeeter, with Ladenburg Thalmann, relayed the highlights from his recent meeting with this company's management team about near-term clinical news and pipeline plans.


Biotech Reports Positive Topline Data; Biologics License Application in Progress (11/06/2017)

Ram Selvaraju, an analyst with H.C. Wainwright & Co., reviewed the recent clinical trial results released by this developer of cell therapies targeting oncology and orphan indications.


Target Price Raised on 'Undervalued' Antibiotics Developer (11/06/2017)

Analyst Ed Arce discussed the rationale behind H.C. Wainwright & Co.'s decision to revise its models on this clinical-stage biopharmaceutical company.


Could a FDA Warning Letter Provide a Silver Lining to This Home Care Medical Device Company? (11/06/2017)

Maj Soueidan, cofounder of GeoInvesting, profiles his long history with a company providing medical devices for the home care market.


Drug Offers 'Best-in-Class' Potential (11/01/2017)

John McCamant, editor of the Medical Technology Stock Letter, initiated coverage on a company that he calls an emerging leader in women's health.


Big Biotech's Value Is Bolstered by Focus on Alzheimer's Disease (11/01/2017)

An analysis of this company's quarterly update highlights a pipeline studded with candidates targeting neurological indications.


More Archives

2023Aug Jul Jun May Apr Mar Feb Jan

2022Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2021Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2020Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2019Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2018Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

Get Our Streetwise Reports' Life Sciences Report Newsletter Free and be the first to know!

A valid email address is required to subscribe

Notable Quotes